Stella Diagnostics Inc.
SLDX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -62.2% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -306.2% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -321.5% | – | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.001 |
| % Growth | -166.7% | 14.3% | 12.5% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |